NCT01125046 2021-01-22Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasNorthwestern UniversityPhase 2 Completed50 enrolled 13 charts
NCT00492089 2014-05-09Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNational Cancer Institute (NCI)Phase 2 Completed11 enrolled 7 charts